Eli Lilly | Lånekapital

Loan Capital Lave om Dato
AbbVie USD 63.81B 8.17B 2024-03
Abbott USD 12.58B 1.99B 2024-03
ALKERMES USD 287.09M 635K 2024-03
Amgen USD 60.06B 3.11B 2024-03
AstraZeneca USD 27.26B 4.04B 2024-03
Baxter International USD 11.09B 38M 2024-03
Biogen USD 6.29B 498.1M 2024-03
Bristol-Myers Squibb USD 49.49B 17.35B 2024-03
Catalent USD 4.93B 26M 2024-03
Drreddys Laboratories INR 6.15B 109M 2023-12
Eli Lilly USD 24.56B 6.64B 2024-03
Gilead Sciences USD 21.53B 1.66B 2024-03
GlaxoSmithKline GBP 15.2B 788M 2023-12
Glaxosmithkline GBP 15.2B 788M 2023-12
J&J USD 25.08B 969M 2024-03
Medtronic USD 24.15B 412M 2024-01
Merck USD 31.14B 2.83B 2024-03
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 17.19B 2.84B 2024-03
Novartis USD 17.19B 2.84B 2024-03
Perrigo USD 3.62B 7.9M 2024-03
Pfizer USD 60.48B 571M 2024-03
Prestige Brands USD 1.13B 73.73M 2024-03
Regeneron Pharmaceuticals USD 1.98B 719.6M 2024-03
Roche Holding CHF 24.81B 4.46B 2023-12
United Therapeutics USD 200M 100M 2024-03
Zoetis USD 6.56B 2M 2024-03



Eli Lilly Lånekapital - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Jun 2024.